Olumiant, Or Baricitinib, Is An Oral Drug Developed By Us Biopharmaceutical Major, Incyte Corporation, And Licensed To Eli LillyUs Pharma Giant Eli Lilly Has Issued Royalty-Free, Non-Exclusive Voluntary Licences To Three Indian Drug Makers
Found this useful? Share it with your team.
